The latest cancer drugs news
Browsing: Cancer Drug News
Shelved anticancer drug could get another shot
A study by Virginia Commonwealth University Massey Cancer Center researchers in the USA, published in Molecular…
Pivotal phase 3 data for pembrolizumab in high-risk early-stage triple-negative breast cancer (TNBC)
Results from the Phase 3 KEYNOTE-522 trial have been published in the New England Journal of…
Ovarian cancer therapy boosted by drug that slows disease’s advance
A drug currently used to treat skin and lung cancers has been found to slow…
NICE recommends nivolumab plus ipilimumab for untreated advanced kidney cancer in intermediate or poor-risk patients
Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence…
Aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in premenopausal as well as postmenopausal women
A new study has shown that giving aromatase inhibitors instead of tamoxifen to premenopausal women…
Promising treatment for deadly brain cancer
A clinical trial has found that selinexor, the first of a new class of anti-cancer…
Trial results indicate trametinib should represent the new standard of care for women with recurrent low-grade serous ovarian cancer
Positive results stemming from the NRG Oncology international phase II/III clinical trial NRG-GOG 0281/LOGS indicate…
Peptide-enhanced anticancer drug targets bone metastasis
A moderate amount of a peptide-enhanced, biological cancer drug goes a long way in treating…
Prodrug that hides like an assassin to kill cancer cells
Assassins conceal their weapons and instantly pull them out as they approach their target to…
Online pharmacy revolutionises generic drug pricing to tackle ‘outrageous markups’
Mark Cuban Cost Plus Drug Company (MCCPDC) recently launched its online pharmacy ‘Cost Plus Drugs’.…